Close Menu

NEW YORK — Anpac Bio-Medical Science on Thursday filed with the US Securities and Exchange Commission for a $21.7 million initial public offering on the Nasdaq.

WestPark Capital is acting as the offering's sole bookrunner. The firm has not priced its shares or said how many shares it plans to offer yet. It said that it plans to trade its shares on the Nasdaq Global Market under ticker symbol "ANPC".

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

This webinar will provide a first-hand look at how a clinical lab evolved its tumor profiling workflow from a targeted panel approach toward comprehensive genomic profiling.  

Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.